|1.||Berger, Julie V: 1 article (10/2011)|
|2.||Nizet, Yannick: 1 article (10/2011)|
|3.||Maloteaux, Jean-Marie: 1 article (10/2011)|
|4.||Hermans, Emmanuel: 1 article (10/2011)|
|5.||Goursaud, Stéphanie: 1 article (10/2011)|
|6.||Focant, Marylène C: 1 article (10/2011)|
|7.||Olivier, Jean-Christophe: 1 article (01/2003)|
|8.||Alleaume, Céline: 1 article (01/2003)|
|9.||Muller, Jean-Marc: 1 article (01/2003)|
|10.||Montoni, Alicia: 1 article (01/2003)|
|1.||Ganglion Cysts (Ganglion)
01/01/1996 - "Other pinealopetal nerve fibres, probably originating in the pterygopalatine ganglion, contain vasoactive intestinal peptide and peptide histidine isoleucine. "
07/01/1996 - "Intrapancreatic ganglion cells were surrounded by numerous VIP- or SP-IR, many Bom- or neuropeptide Y (NPY)-IR, several calcitonin gene-related peptide (CGRP)- or peptide histidine isoleucine IR and a few NOS- or CCK-IR nerve terminals. "
09/12/1994 - "In some parasympathetic ganglia such as the sphenopalatine and submandibular ganglia NOS-LI was present in most ganglion cells, at least partly coexisting with peptide histidine isoleucine (PHI), vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY). "
02/01/1994 - "In adult retinas, vasoactive intestinal polypeptide/peptide histidine isoleucine messenger RNA is localized to amacrine cells positioned in the proximal inner nuclear layer, and rarely to displaced amacrine cells in the inner plexiform layer and ganglion cell layer. "
01/01/1991 - "These data demonstrate that vasoactive intestinal peptide- and peptide histidine amide-like immunoreactivities are present in certain of the preganglionic neurons that project to the superior cervical ganglion, supporting the hypothesis that vasoactive intestinal peptide and peptide histidine isoleucine amide are released in the ganglion when these preganglionic neurons are activated."
05/01/1991 - "We examined whether peptide histidine methionine (PHM) induces a paradoxical rise in plasma GH in patients with acromegaly. "
08/01/1994 - "We examined whether the cholinergic mechanism is involved in the paradoxical GH responses to vasoactive intestinal peptide (VIP) and peptide histidine methionine (PHM) in acromegaly. "
10/01/1992 - "We examined whether the GH-releasing effect of peptide histidine methionine (PHM) in acromegaly may be mediated by activation of pituitary receptors for vasoactive intestinal peptide (VIP), which is structurally similar to but more powerful than PHM in stimulating GH secretion in acromegaly. "
10/01/1992 - "A further study on the stimulatory effect of peptide histidine methionine on growth hormone secretion in acromegaly: a dose-related study and a comparison with vasoactive intestinal peptide."
11/01/1991 - "For comparison, we assessed in all the patients the effects of TRH (500 micrograms), GnRH (100 micrograms), vasoactive intestinal peptide (100 micrograms) and peptide histidine methionine (100 micrograms), which are known paradoxically to stimulate GH secretion in acromegaly. "
05/01/1993 - "The authors examined the distribution of several peptides--VIP, peptide histidine methionine (PHM), neuropeptide Y (NPY), methionine-enkephalin (M-EK), somatostatin (SS), substance-P (Sub-P), corticotropin-releasing hormone, and tyrosine hydroxylase--with immunohistochemical studies and an in situ hybridization method in three ganglioneuroblastomas with WDHA syndrome. "
|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
02/01/1990 - "Studies were carried out using cultured fibroblasts from two patients with psoriasis from uninvolved and involved areas of skin and from two controls using antibodies to PNMT, as well as antibodies to the chemical messengers somatostatin, substance P, parathyroid hormone and peptide histidine isoleucine amide. "
04/01/1988 - "Mucosal-submucosal concentrations of peptide histidine-methionine were significantly decreased in ulcerative colitis and Crohn's colitis, compared to those in normal colon. "
04/01/1988 - "Since our previous study using radioimmunoassay had demonstrated significantly decreased colonic concentrations of vasoactive intestinal polypeptide in ulcerative colitis and Crohn's colitis compared to normal colon, we determined the distribution and quantitation of peptide histidine-methionine. "
04/01/1988 - "However, a parallel decrease in molar concentrations of peptide histidine-methionine and vasoactive intestinal polypeptide in ulcerative colitis and Crohn's colitis was demonstrated by linear correlation analysis. "
|1.||Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
|4.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|5.||Peptide PHI (Peptide Histidine-Isoleucine)
|6.||Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)
|7.||Growth Hormone (Somatotropin)